Skip to main content
. 2023 Sep 8;2023(9):CD001888. doi: 10.1002/14651858.CD001888.pub5

20. Overview of results: Obstetrics.

Outcome Total
(95% CI)
Subgroup: blood salvage (collection time) Subgroup: transfusion threshold
Intraoperative Postoperative Both No transfusion threshold Liberal threshold (Hb > 80 g/L) Restrictive threshold (Hb80 g/L)
Risk of transfusion POR 0.82 [0.38, 1.76]
1 RCT, N = 1349
⨁⨁◯◯
POR 0.82 [0.38, 1.76]
1 RCT, N = 1349
⨁⨁◯◯
    POR 0.82 [0.38, 1.76]
1 RCT, N = 1349
⨁⨁◯◯
   
Volume transfused (PPR) MD ‐0.02 [‐0.08, 0.04]
1 RCT, N = 1349
⨁⨁⨁⨁
MD ‐0.02 [‐0.08, 0.04]
1 RCT, N = 1349
⨁⨁⨁⨁
    MD ‐0.02 [‐0.08, 0.04]
1 RCT, N = 1349
⨁⨁⨁⨁
   
Volume transfused (PPT) MD ‐0.41 [‐2.26, 1.44]
1 RCT, N = 27
⨁⨁◯◯
MD ‐0.41 [‐2.26, 1.44]
1 RCT, N = 27
⨁⨁◯◯
    MD ‐0.41 [‐2.26, 1.44]
1 RCT, N = 27
⨁⨁◯◯
   
All‐cause mortality              
Blood loss              
Re‐operation              
Infection              
Wound complication              
VTE/thrombosis              
DVT              
PE              
MACE              
MI              
CVA/stroke              
Hospital LOS              

Bolded data highlights where there was a clear intervention effect.

"Volume" refers to mean transfusion volume; "transfusions" refers to number of people receiving an allogeneic transfusion

CI: confidence interval; CVA: cerebrovascular accident; DVT: deep vein thrombosis; Hb: haemoglobin; LOS: hospital length of stay; MACE: major adverse cardiovascular events; MD: mean difference; MI: myocardial infarction; N: number of people analysed; PE: pulmonary embolism; PJI: prosthetic joint infection; POR: Peto odds ratio; PPR: per person randomised; PPT: per person transfused; RCT: randomised controlled trial; RD: risk difference; RR: risk ratio; VTE: venous thromboembolism

⨁◯◯◯ = Very low certainty; ⨁⨁◯◯ = Low certainty; ⨁⨁⨁◯ = Moderate certainty; ⨁⨁⨁⨁ = High certainty